secwatch.observer — SEC 8-K summary
======================================

Issuer:     Atea Pharmaceuticals, Inc. (AVIR)
CIK:        0001593899
Form:       8-K
Filed at:   2021-07-23T23:59:59+00:00
Accession:  0001193125-21-223025
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Atea Pharmaceuticals subleases Boston HQ; monthly rent $65,790 starting Jan 2022
--------------------------------------------------------------------------------

- Sublease 17,544 sq ft at 225 Franklin St, Boston; term Jan 1, 2022 to Dec 31, 2026.
- Base rent $65,790/month (year 1), increasing 2% annually; plus operating expenses and taxes.
- Sublandlord DataRobot provides $877,200 leasehold improvement allowance.
- Existing lease at 125 Summer St expires July 2022; new space to be principal executive offices.
- Sublease conditioned on Prime Landlord consent and continued existence of prime lease.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1593899/000119312521223025/0001193125-21-223025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1593899/000119312521223025/d69975d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-223025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer